StockData

Generate Biomedicines, Inc. (GENB) stock

GENBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$10.38+0.54 (+5.49%)

Close on Nov 18, 2026Market cap $1.33BP/E –Yield –

Generate Biomedicines shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Generate Biomedicines's shares outstanding was 129M at Sep 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026129M+289.5%
Q2 FY2026Jun 30, 2026128M+291.1%
Q1 FY2026Mar 31, 202665M–
Q3 FY2025Sep 30, 202533M–
Q2 FY2025Jun 30, 202533M–
Q1 FY2025Mar 31, 202533M–

More Generate Biomedicines figures

See a number that looks wrong?